Sunday, October 18, 2026 SourcesAbout🌓
🇺🇸 US ▾
BREAKING
Latest

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

The New York Times ·
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.

Read the full article on The New York Times ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.nytimes.com — the content belongs to The New York Times.

More from The New York Times

See all ›

More in Latest

See all ›